Search Results - "Lutchminarain, Keeren"

Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial) by Martinson, Neil A, Nonyane, Bareng A S, Genade, Leisha P, Berhanu, Rebecca H, Naidoo, Pren, Brey, Zameer, Kinghorn, Anthony, Nyathi, Sipho, Young, Katherine, Hausler, Harry, Connell, Lucy, Lutchminarain, Keeren, Swe Swe-Han, Khine, Vreede, Helena, Said, Mohamed, von Knorring, Nina, Moulton, Lawrence H, Lebina, Limakatso

“…The World Health Organization (WHO) recommends systematic symptom screening for tuberculosis (TB). However, TB prevalence surveys suggest that this strategy…”
Get full text

Southern African HIV Clinicians Society guideline on the management of non-tuberculous mycobacteria in people with HIV by Dawood, Halima, Richards, Lauren, Lutchminarain, Keeren, Parker, Arifa, Wattrus, Camilla, Sipambo, Nosisa, Nel, Jeremy, Manzini, Thandekile, Naidoo, Kogieleum

“…No Abstract required…”
Get full text

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients by Nimmo, Camus, Millard, James, Brien, Kayleen, Moodley, Sashen, van Dorp, Lucy, Lutchminarain, Keeren, Wolf, Allison, Grant, Alison D, Balloux, Francois, Pym, Alexander S, Padayatchi, Nesri, O'Donnell, Max

“…Global tuberculosis (TB) control is threatened by drug resistance, with over 500 000 cases resistant to first-line drugs in 2018 [1]. Bedaquiline is a highly…”
Get full text

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis by Mvelase, Nomonde Ritta, Balakrishna, Yusentha, Lutchminarain, Keeren, Mlisana, Koleka

“…ObjectivesSouth Africa ranks among the highest drug-resistant tuberculosis (DR-TB) burdened countries in the world. This study assessed the changes in…”
Get full text

Performance of the GenoType MTBDRsl in a programmatic setting, South Africa by Lutchminarain, K., Kajee, A., Gandhi, N. R., Han, K. S. S., Mvelase, N.

“…BACKGROUND: The GenoType MTBDRsl v2 is a molecular test designed for the rapid detection of resistance to second-line anti-TB drugs in Mycobacterium…”
Get full text

The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis by Harrington, Kristin R.V., Gandhi, Neel R., Shah, N. Sarita, Naidoo, Kogieleum, Auld, Sara C., Andrews, Jason R., Brust, James C.M., Lutchminarain, Keeren, Coe, Megan, Willis, Fay, Campbell, Angie, Cohen, Ted, Jenness, Samuel M., Waller, Lance A.

“…We sought to understand the impact of the initial COVID-19 mitigation strategies in 2020 on drug-resistant (DR) TB diagnoses in KwaZulu-Natal province (KZN),…”
Get full text